Status:

COMPLETED

A Study to Explore Hereditary Angioedema (HAE) Symptoms and Treatment Patterns in Korean People

Lead Sponsor:

Takeda

Conditions:

Hereditary Angioedema (HAE)

Eligibility:

All Genders

Brief Summary

This study intends to gather information on HAE attack symptoms, how often the attacks occur, and the number of times treatment is required to manage the attacks in Korean people over a period of up t...

Eligibility Criteria

Inclusion

  • Participants who are participants in the OnHeart PSP program.
  • Participants who have registered in "MyHAE Story" mobile application.

Exclusion

  • \- Participants who neither have made input to at least one attack nor have run the app by clicking 'myHAE story' tab within the Kakaotalk chat message at least once after app registration.

Key Trial Info

Start Date :

October 16 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 18 2024

Estimated Enrollment :

19 Patients enrolled

Trial Details

Trial ID

NCT06587464

Start Date

October 16 2024

End Date

December 18 2024

Last Update

February 10 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Seoul National University Hospital

Seoul, South Korea, 03080